10 Prediksi Pasar Saham untuk Tahun 2025
expected to reschedule cannabis from a Schedule I drug to a Schedule II drug. This move would allow for greater research and potentially open the door for federal legalization in the future. With this change on the horizon, cannabis stocks are poised for a major rebound in 2025. Companies like Canopy Growth (NASDAQ: CGC) and … Baca Selengkapnya